CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients... von Chiorean, E.G., Von Hoff, D.D., Reni, M., Arena, F.P., Infante, J.R., Bathini, V.G., Wood, T.E., Mainwaring, P.N., Muldoon, R.T., Clingan, P.R., Kunzmann, V., Ramanathan, R.K., Tabernero, J., Goldstein, D., McGovern, D., Lu, B., Ko, A.

Volltext

Treatment of hepatic metastases by cryotherapy and regional cytotoxic perfusion von Morris, D L, Horton, M D, Dilley, A V, Warlters, A, Clingan, P R

Volltext

Randomized phase III trial of amrubicin versus topotecan (Topo) as second-line treatment for small cell lung cancer (SCLC) von Jotte, R., Von Pawel, J., Spigel, D. R., Socinski, M. A., O'Brien, M., Paschold, E. H., Mezger, J., Steins, M., Bosquée, L., Bubis, J. A., Nackaerts, K., Trigo Perez, J. M., Clingan, P. R., Schuette, W., Lorigan, P., Reck, M., Domine, M., Shepherd, F. A., McNally, R., Renschler, M. F.

Volltext

Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy von Preketes, A. P., Caplehorn, J. R. M., King, J., Clingan, P. R., Ross, W. B., Morris, D. L.

Volltext

469PSafety, efficacy, and pharmacokinetic (PK) profile of cosibelimab, an anti‐PD‐L1 antibody, in patients (pts) with advanced cancers von Clingan, P R, Mant, A M, Richardson, G E, Kowalski, D M, Koralewski, P, Lugowska, I, Dechaphunkul, A, Charoentum, C, Sookprasert, A, Sriuranpong, V, Akopov, A, Kozlov, V, Fadeeva, N, Kasparov, B, Kovalenko, N V, Oschepkov, V, Gorelik, L, Kunes, Y, Oliviero, J, Harris, D L

Volltext

Breast Appearance and Function After Breast Conserving Surgery and Radiotherapy von Hamilton, C. S., Nield, J. M., Adler, G. F., Clingan, P. R.

Volltext

Primary resection and synchronous regional hepatic chemotherapy or cryotherapy for colorectal cancer with liver metastases von DASAPPA, V, ROSS, W. B, KING, J, KING, D. W, CLINGAN, P. R, MORRIS, D. L

Volltext

Phase II study of PRO95780 plus paclitaxel, carboplatin, and bevacizumab (PCB) in non-small cell lung cancer (NSCLC) von Karapetis, C. S., Clingan, P. R., Leighl, N. B., Durbin-Johnson, B., O'Neill, V., Spigel, D. R.

Volltext

FOLFOX4 as adjuvant therapy in elderly patients (pts) with colon cancer (CC): Subgroup analysis of the MOSAIC trial von Tournigand, C., Andre, T., Bachet, j., Teixeira, L., Boni, C., Clingan, P. R., Hickish, T., Tabernero, J., De Gramont, A.

Volltext

A phase II study of tasisulam sodium (LY573636) as second-line treatment for patients with unresectable or metastatic melanoma von Kirkwood, J. M., Gonzalez, R., Reintgen, D. S., Clingan, P. R., McWilliams, R. R., Ilaria, R. L., de Alwis, D. P., Zimmermann, A., Brown, M. P., Millward, M.

Volltext

Results of Breast Conserving Treatment of Breast Cancer von Hamilton, C. S., Nield, J. M., Adler, G. F., Clingan, P. R.

Volltext

A randomized trial of cimetidine with 5-fluorouracil and folinic acid in metastatic colorectal cancer von Links, Matthew, Clingan, Philip R., Phadke, Kiran, O'Baugh, Jenny, Legge, Janet, Adams, Warwick J., Ross, William B., Morris, David L.

Volltext

Preclinical evaluation of novel, all-in-one formulations of 5-fluorouracil and folinic acid with reduced toxicity profiles von Stutchbury, Tamantha K, Vine, Kara L, Locke, Julie M, Chrisp, Jeremy S, Bremner, John B, Clingan, Philip R, Ranson, Marie

Volltext

Development and assessment of novel all-in-one parenteral formulations with integrated anticoagulant properties for the concomitant delivery of 5-fluorouracil and calcium folinate von Locke, Julie M, Stutchbury, Tamantha K, Vine, Kara L, Gamble, Allan B, Clingan, Philip R, Bremner, John B, Ranson, Marie

Volltext

PREVIOUS INTRAVENOUS CHEMOTHERAPY DOES NOT ALTER RESPONSE RATE OR SURVIVAL TIME OF PATIENTS WITH HEPATIC METASTASES FROM COLORECTAL CANCER TREATED BY HEPATIC ARTERY CHEMOTHERAPY von Morris, David L., Zhao, Jing, Clingan, Philip R.

Volltext

Echogenicity of liver metastases from colorectal carcinoma is an independent prognostic factor in patients treated with regional chemotherapy von Gruenberger, Thomas, Zhao, Jing, King, Julie, Chung, TengTeng, Clingan, Phil R., Morris, David L.

Volltext

Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy. Commentary von PREKETES, A. P, CAPLEHORN, J. R. M, KING, J, CLINGAN, P. R, ROSS, W. B, MORRIS, D. L, RAVIKUMAR, T. S

Volltext

CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients... von Chiorean, EG, Von Hoff, DD, Reni, M, Arena, FP, Infante, JR, Bathini, VG, Wood, TE, Mainwaring, PN, Muldoon, RT, Clingan, PR, Kunzmann, V, Ramanathan, RK, Tabernero, J, Goldstein, D, McGovern, D, Lu, B, Ko, A

Volltext bestellen

Radiologically placed hepatic artery catheter allows selection of patients with high-volume liver metastases for regional chemotherapy von Zhao, Jing, Clingan, Philip R, Glenn, Derek, Morris, David L

Volltext

Baseline Characteristics of Participants in the Randomized National Lung Screening Trial von Aberle, Denise R., Adams, Amanda M., Berg, Christine D., Clapp, Jonathan D., Clingan, Kathy L., Gareen, Ilana F., Lynch, David A., Marcus, Pamela M., Pinsky, Paul F.

Volltext